Universiteit Leiden

nl en

Willemijn Meijer

Name
Dr. W.M. Meijer
Telephone
+31 71 527 3817
E-mail
w.m.meijer@fsw.leidenuniv.nl

Willemijn Meijer is a postdoc at the Centre for Child and Family Studies, Leiden University

More information about Willemijn Meijer

Short CV

Willemijn Meijer studied pharmacy in Groningen, where she obtained her Masters in 1999 and her PharmD in 2001. In 2006, she successfully defended her doctoral thesis ‘Drug safety in pregnancy: studying and communicating teratogenic risks’. This thesis was based on studies using the EUROCAT database (European surveillance of congenital anomalies), the IADB (Dutch prescription database) and the Birth Defects Data of the Slone Epidemiology Centre (Boston, US). Besides epidemiologic studies, her thesis held two studies on the implementation of an intervention in community pharmacies. Willemijn increased her knowledge in epidemiology and large databases working as a research manager at the PHARMO Institute for Drug Outcomes Research for four years. After a year as postdoc at Erasmus MC , Willemijn applied her scientific experience in developing  evidence based guidelines for pharmaceutical care provided by community pharmacists. Currently, Willemijn is involved in the project Father Trials.

Research by

Willemijn Meijer is currently involved in the project Father Trials with a focus on hormones as well as on data management.

Selected publications

Scholarly

  • Heringa M., Floor A., Meijer W.M., De Smet P.A., Bouvy M.L. (2015), Nature and management of duplicate medication alerts, J Am Med Inform Assoc. 22(4):831-7.

  • Wijnands K.P., Zeilmaker G.A., Meijer W.M., Helbing W.A., Steegers-Theunissen R.P.  (2014), Periconceptional parental conditions and perimembranous ventricular septal defects in the offspring, Birth Defects Res A Clin Mol Teratol 100(12):944-50.

  • van den Ban E., Souverein P., Meijer W., van Engeland H., Swaab H., Egberts T., Heerdink E. (2014), Association between ADHD drug use and injuries among children and adolescents, Eur Child Adolesc Psychiatry 23(2):95-102.

  • Houweling L.M., Bezemer I.D., Penning-van Beest .FJ., Meijer W.M., van Lingen R.A., Herings R.M. (2013), First year of life medication use and hospital admission rates: premature compared with term infants, J Pediatr 163(1):61-6.e1.

  • Penning-van Beest F.J., Overbeek J.A., Meijer W.M., Woodruff K., Jackson J., van der Vis H., van der Linden P., Herings R.M. (2011), Venous thromboembolism prophylaxis after total knee or hip replacement: treatment pattern and outcomes, Pharmacoepidemiol Drug Saf  20(9):972-8.

  • Hodgkins P., Sasané R., Meijer W.M. (2011), Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands, Clin Ther 33(2):188-203.

  • Sasané R., Hodgkins P., Meijer W.  (2010), Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands, Curr Med Res Opin 26(11):2565-74.

  • Meijer W.M., Faber A., van den Ban E., Tobi H. (2009), Current issues around the pharmacotherapy of ADHD in children and adults, Pharm World Sci 31(5):509-16.

  • Wakkee M., Meijer W.M., Neumann H.A.M., Herings R.M.C., Nijsten T. (2009), Psoriasis may not be an independent predictor for the use of cardiovascular and antidiabetic drugs: results from a 5-year prevalence study, Acta Derm Venereol 89(5):476-83.

  • Meijer W.M., Penning-van Beest F.J., Olson M., Herings R.M. (2008), Relationship between duration of compliant bisphosphonate use and the risk of osteoporotic fractures, Curr Med Res Opin 24(11):3217-22.

  • Meijer W.M., Cornel M.C., Dolk H., de Walle H.E., Armstrong N.C., de Jong-van den Berg L.T. EUROCAT Working Group (2006), The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study, Pharmacoepidemiol Drug Saf 15(9):675-82.

  • Meijer W.M., de Jong-Van den Berg L.T., van den Berg M.D., Verheij J.B., de Walle H.E. (2006), Clomiphene and hypospadias on a detailed level: signal or chance? Birth Defects Res A Clin Mol Teratol 76(4):249-52.

  • Meijer W.M., Werler M.M., Louik C., Hernandez-Diaz S., de Jong-van den Berg L.T., Mitchell A.A. (2006), Can folic acid protect against congenital heart defects in Down syndrome? Birth Defects Res A Clin Mol Teratol 76(10):714-7.

  • Meijer W.M., de Walle H.E., Kerstjens-Frederikse W.S., de Jong-van den Berg L.T. (2005), Folic acid sensitive birth defects in association with intrauterine exposure to folic acid antagonists. Reprod Toxicol 20(2):203-7.

  • Meijer W., de Smit D., Jurgens R., de Jong-van den Berg L. (2005), Improved periconceptional use of folic acid after patient education in pharmacies – promising results of a pilot study in the Netherlands. IJPP 13: 47-51.

  • Meijer W., de Smit D., Jurgens R., de Jong-van den Berg L. (2004), Pharmacists’ role in awareness about folic acid: the process of introducing an intervention in pharmacy practice. IJPP 12: 29-35.

  • Schirm E., Meijer W.M., Tobi H., de Jong-van den Berg L.T. (2004), Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system, Eur J Obstet Gynecol Reprod Biol 114(2):182-8.

  • Tobi H., Meijer W.M., Tuinstra J., de Jong-van den Berg L.T. (2003), Socio-economic differences in prescription and OTC drug use in Dutch adolescents, Pharm World Sci 25(5):203-6.

Professional

  • Fokkema M.R., Meijer W.M., de Jong-van den Berg L.T.W. (2005), Benefits and concerns regarding folic-acid fortification. Ned Tijdschr Klin Chem Labgeneesk 30: 218-223

  • Meijer W.M., de Walle H.E.K. (2005), Verschillen in foliumzuurbeleid en prevalentie van neurale buisdefecten in Europa; aanbevelingen voor voedselverrijking in een EUROCAT-rapport. NTvG 149(46): 2561-4.

  • Vanhecken S., Penders E., Sarre S., de Walle H.E.K., Meijer W.M., de Jong-van den Berg L.T.W. (2004), Foliumzuur rond de conceptie: de situatie in België. Farmaceutisch Tijdschrift voor België 2004; 1: 3-7.

  • Meijer W.M. (2004), Kan foliumzuur ter preventie van foetale neurale buisdefecten ook minder vaak, maar in hogere dosering worden toegediend? Vademecum Permanente Nascholing Huisartsen 22(41).

  • Meijer W. (2003), Zwangerschap en lactatie bewaken: een onderzoek. Pharmaceutisch Weekblad 2003;138 (11):381.

  • Faculteit der Sociale Wetenschappen
  • Instituut Pedagogische Wetenschappen
  • Instituutsbureau Pedagogiek

Work address

Pieter de la Court Building
Wassenaarseweg 52
2333 AK Leiden
Room number 5A33

Contact

  • Geen relevante nevenwerkzaamheden

This website uses cookies. More information